Synthesis, antiproliferative, and c-Src kinase inhibitory activities of 4-oxo-4H-1-benzopyran derivatives

Karam Chand, Rakesh K. Tiwari, Sumit Kumar, Amir Nasrolahi Shirazi, Sweta Sharma, Erik V. Van Der Eycken, Virinder S. Parmar, Keykavous Parang, Sunil K. Sharma

Research output: Contribution to journalArticle

Abstract

A new class of 4-oxo-4H-1-benzopyran derivatives were synthesized and their antiproliferative activity examined against a panel of three human cancer cell lines, that is, breast carcinoma (MDA-MB-468), ovarian adenocarcinoma (SK-OV-3), and colorectal adenocarcinoma (HT-29). Two compounds, that is, 3-hexyl-7,8-dihydroxy-4-oxo-4H-1-benzopyran and (E)-ethyl 3-(7-methoxy-4-oxo-4H-1-benzopyran-3-yl)acrylate were found to be potent against all three cancer cell lines studied at 50 μM concentration. Also, the inhibitory potency of the compounds was evaluated against active Src kinase. A few of these compounds exhibited modest Src kinase inhibitory activity (IC50 = 52-57 μM). Structure-activity relationship studies with respect to the nature and position of substituents on the lead compounds could be further exploited for the design and development of more potent antiproliferative agents and/or Src kinase inhibitors.

Original languageEnglish (US)
Pages (from-to)562-572
Number of pages11
JournalJournal of Heterocyclic Chemistry
Volume52
Issue number2
DOIs
StatePublished - 2015
Externally publishedYes

Fingerprint

Benzopyrans
src-Family Kinases
Derivatives
Cells
Lead compounds
CSK tyrosine-protein kinase

ASJC Scopus subject areas

  • Organic Chemistry

Cite this

Chand, K., Tiwari, R. K., Kumar, S., Shirazi, A. N., Sharma, S., Van Der Eycken, E. V., ... Sharma, S. K. (2015). Synthesis, antiproliferative, and c-Src kinase inhibitory activities of 4-oxo-4H-1-benzopyran derivatives. Journal of Heterocyclic Chemistry, 52(2), 562-572. https://doi.org/10.1002/jhet.2106

Synthesis, antiproliferative, and c-Src kinase inhibitory activities of 4-oxo-4H-1-benzopyran derivatives. / Chand, Karam; Tiwari, Rakesh K.; Kumar, Sumit; Shirazi, Amir Nasrolahi; Sharma, Sweta; Van Der Eycken, Erik V.; Parmar, Virinder S.; Parang, Keykavous; Sharma, Sunil K.

In: Journal of Heterocyclic Chemistry, Vol. 52, No. 2, 2015, p. 562-572.

Research output: Contribution to journalArticle

Chand, K, Tiwari, RK, Kumar, S, Shirazi, AN, Sharma, S, Van Der Eycken, EV, Parmar, VS, Parang, K & Sharma, SK 2015, 'Synthesis, antiproliferative, and c-Src kinase inhibitory activities of 4-oxo-4H-1-benzopyran derivatives', Journal of Heterocyclic Chemistry, vol. 52, no. 2, pp. 562-572. https://doi.org/10.1002/jhet.2106
Chand, Karam ; Tiwari, Rakesh K. ; Kumar, Sumit ; Shirazi, Amir Nasrolahi ; Sharma, Sweta ; Van Der Eycken, Erik V. ; Parmar, Virinder S. ; Parang, Keykavous ; Sharma, Sunil K. / Synthesis, antiproliferative, and c-Src kinase inhibitory activities of 4-oxo-4H-1-benzopyran derivatives. In: Journal of Heterocyclic Chemistry. 2015 ; Vol. 52, No. 2. pp. 562-572.
@article{090db26b80044145bceb70f127b83d87,
title = "Synthesis, antiproliferative, and c-Src kinase inhibitory activities of 4-oxo-4H-1-benzopyran derivatives",
abstract = "A new class of 4-oxo-4H-1-benzopyran derivatives were synthesized and their antiproliferative activity examined against a panel of three human cancer cell lines, that is, breast carcinoma (MDA-MB-468), ovarian adenocarcinoma (SK-OV-3), and colorectal adenocarcinoma (HT-29). Two compounds, that is, 3-hexyl-7,8-dihydroxy-4-oxo-4H-1-benzopyran and (E)-ethyl 3-(7-methoxy-4-oxo-4H-1-benzopyran-3-yl)acrylate were found to be potent against all three cancer cell lines studied at 50 μM concentration. Also, the inhibitory potency of the compounds was evaluated against active Src kinase. A few of these compounds exhibited modest Src kinase inhibitory activity (IC50 = 52-57 μM). Structure-activity relationship studies with respect to the nature and position of substituents on the lead compounds could be further exploited for the design and development of more potent antiproliferative agents and/or Src kinase inhibitors.",
author = "Karam Chand and Tiwari, {Rakesh K.} and Sumit Kumar and Shirazi, {Amir Nasrolahi} and Sweta Sharma and {Van Der Eycken}, {Erik V.} and Parmar, {Virinder S.} and Keykavous Parang and Sharma, {Sunil K.}",
year = "2015",
doi = "10.1002/jhet.2106",
language = "English (US)",
volume = "52",
pages = "562--572",
journal = "Journal of Heterocyclic Chemistry",
issn = "0022-152X",
publisher = "Heterocorporation",
number = "2",

}

TY - JOUR

T1 - Synthesis, antiproliferative, and c-Src kinase inhibitory activities of 4-oxo-4H-1-benzopyran derivatives

AU - Chand, Karam

AU - Tiwari, Rakesh K.

AU - Kumar, Sumit

AU - Shirazi, Amir Nasrolahi

AU - Sharma, Sweta

AU - Van Der Eycken, Erik V.

AU - Parmar, Virinder S.

AU - Parang, Keykavous

AU - Sharma, Sunil K.

PY - 2015

Y1 - 2015

N2 - A new class of 4-oxo-4H-1-benzopyran derivatives were synthesized and their antiproliferative activity examined against a panel of three human cancer cell lines, that is, breast carcinoma (MDA-MB-468), ovarian adenocarcinoma (SK-OV-3), and colorectal adenocarcinoma (HT-29). Two compounds, that is, 3-hexyl-7,8-dihydroxy-4-oxo-4H-1-benzopyran and (E)-ethyl 3-(7-methoxy-4-oxo-4H-1-benzopyran-3-yl)acrylate were found to be potent against all three cancer cell lines studied at 50 μM concentration. Also, the inhibitory potency of the compounds was evaluated against active Src kinase. A few of these compounds exhibited modest Src kinase inhibitory activity (IC50 = 52-57 μM). Structure-activity relationship studies with respect to the nature and position of substituents on the lead compounds could be further exploited for the design and development of more potent antiproliferative agents and/or Src kinase inhibitors.

AB - A new class of 4-oxo-4H-1-benzopyran derivatives were synthesized and their antiproliferative activity examined against a panel of three human cancer cell lines, that is, breast carcinoma (MDA-MB-468), ovarian adenocarcinoma (SK-OV-3), and colorectal adenocarcinoma (HT-29). Two compounds, that is, 3-hexyl-7,8-dihydroxy-4-oxo-4H-1-benzopyran and (E)-ethyl 3-(7-methoxy-4-oxo-4H-1-benzopyran-3-yl)acrylate were found to be potent against all three cancer cell lines studied at 50 μM concentration. Also, the inhibitory potency of the compounds was evaluated against active Src kinase. A few of these compounds exhibited modest Src kinase inhibitory activity (IC50 = 52-57 μM). Structure-activity relationship studies with respect to the nature and position of substituents on the lead compounds could be further exploited for the design and development of more potent antiproliferative agents and/or Src kinase inhibitors.

UR - http://www.scopus.com/inward/record.url?scp=84925341388&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925341388&partnerID=8YFLogxK

U2 - 10.1002/jhet.2106

DO - 10.1002/jhet.2106

M3 - Article

VL - 52

SP - 562

EP - 572

JO - Journal of Heterocyclic Chemistry

JF - Journal of Heterocyclic Chemistry

SN - 0022-152X

IS - 2

ER -